Reinsurance Group of America (RGA) is back in focus after Q1 2026 results comfortably beat analyst forecasts on revenue and earnings, yet the stock’s recent moves reflect ongoing questions about premium growth and capital generation.

Despite record Q1 earnings and a newly filed universal shelf registration that gives RGA flexibility to issue various securities, the share price has eased in recent months. The 90 day share price return of 5.29% is down even as the 5 year total shareholder return of 87.62% points to much stronger longer term gains.

If RGA’s recent moves have you thinking about where else capital could go to work, this could be a good moment to uncover 18 top founder-led companies

With record Q1 earnings, a universal shelf in place, and the stock roughly 19% below the average analyst price target, the key question is simple: Is RGA undervalued, or is the market already pricing in its future growth?

Most Popular Narrative: 15.4% Undervalued

Reinsurance Group of America’s most followed narrative points to a fair value of $248.44 versus the last close of $210.15, framing a gap that hinges on long term earnings power and capital deployment.

Recent material improvements in deployable and excess capital, enabled by new in-force value credits and a strong balance sheet, provide RGA with the flexibility to pursue high-return new business, return capital to shareholders via buybacks/dividends, and deploy capital for select accretive acquisitions, all supporting future EPS and ROE uplift.

Analysts are not just plugging in generic growth. The narrative leans on specific revenue expansion assumptions, higher profit margins, and a lower future earnings multiple to reconcile that fair value gap.

Result: Fair Value of $248.44 (UNDERVALUED)

However, that upside narrative still hinges on more stable claims experience and controlled medical costs, with any renewed volatility or cost pressure quickly challenging those fair value assumptions.

Another Check: P/E Sends a Different Signal

While the consensus fair value suggests RGA is 15.4% undervalued, the current P/E of 11.2x tells a more cautious story. It sits above peers at 6.1x, yet below a fair ratio of 14.7x. This points to both valuation risk and potential room for rerating. Which side of that gap matters more to you?

Next Steps

If this mix of optimism and caution leaves you unsure, it is worth checking the underlying data yourself and deciding quickly where you stand. To see what investors are currently optimistic about, review the 4 key rewards.

Looking for more investment ideas?

If RGA has sharpened your focus, do not stop here. Widening your search now could reveal opportunities that others overlook.

• Target consistent income by checking out 14 dividend fortresses that might suit a portfolio focused on regular cash returns.
• Hunt for quality at a fair price by using the screener containing 21 high quality undiscovered gems before these companies attract wider attention.
• Prioritise resilience by reviewing the 66 resilient stocks with low risk scores that may offer steadier performance across different market conditions.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.